rs140743001
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PVS1PP5
The NM_001267550.2(TTN):c.44272C>T(p.Arg14758Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.44272C>T | p.Arg14758Ter | stop_gained | 239/363 | ENST00000589042.5 | NP_001254479.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.44272C>T | p.Arg14758Ter | stop_gained | 239/363 | 5 | NM_001267550.2 | ENSP00000467141 | P1 | |
TTN-AS1 | ENST00000659121.1 | n.502+32569G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151846Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000805 AC: 2AN: 248384Hom.: 0 AF XY: 0.00000742 AC XY: 1AN XY: 134732
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460806Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726678
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151964Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74236
ClinVar
Submissions by phenotype
not provided Pathogenic:4Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 12, 2016 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2023 | Reported in association with DCM, LVNC and familial atrial fibrillation (PMID: 27532257, 30333491, 31737537, 33500567, 33106378, 33996946, 36264615); Not observed at significant frequency in large population cohorts (gnomAD); Located in a region of TTN within the I-band in which the majority of loss of function variants are significantly associated with autosomal dominant titinopathies (PMID: 27625338, 27869827); This variant is associated with the following publications: (PMID: 22335739, 24503780, 30333491, 33874732, 33106378, 31737537, 33500567, 31112426, 27625338, 27869827, 33996946, 27532257, 36264615) - |
Likely pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Jul 30, 2016 | - - |
Dilated cardiomyopathy 1G Pathogenic:3
Likely pathogenic, no assertion criteria provided | clinical testing | Cardiogenetics and Myogenetics Molecular and Cellular Functional Unit, Aphp Sorbonne University-Hopital Pitie Salpetriere | Jan 06, 2024 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 30, 2023 | The TTN c.44272C>T (p.Arg14758Ter) is a nonsense variant, located in exon 239 of the meta transcript of titin within the I-band, which is highly expressed in cardiac tissue (PMID:25589632). In a meta-analysis of TTN truncating variants in DCM patients and controls, variants in this region were associated with a significantly increased risk of developing DCM (odds ratio 19.5) (PMID:27869827). The p.Arg14758Ter variant has been reported in the literature in one patient with dilated cardiomyopathy (PMID:27532257). This variant is reported in the Genome Aggregation Database in three alleles at a frequency of 0.000026 in the Total population (version 3.1.2). Based on the available evidence the c.44272C>T (p.Arg14758Ter) variant is classified as likely pathogenic for dilated cardiomyopathy. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues | Nov 16, 2016 | - - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 12, 2023 | This sequence change creates a premature translational stop signal (p.Arg14758*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (rs140743001, gnomAD 0.003%). This premature translational stop signal has been observed in individuals with dilated cardiomyopathy and/or left ventricular noncompaction (PMID: 27532257, 31737537, 33500567, 33874732; Invitae). ClinVar contains an entry for this variant (Variation ID: 202367). This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). Truncating variants in this region have also been identified in individuals affected with autosomal dominant dilated cardiomyopathy and/or cardio-related conditions (PMID: 27869827, 32964742). For these reasons, this variant has been classified as Pathogenic. - |
Primary dilated cardiomyopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 03, 2016 | The p.Arg12190X variant in TTN has been identified by our laboratory in 1 Caucas ian individual with DCM and 1 Caucasian individual with LVNC (LMM data). This va riant has also been identified in 1/67564 European chromosomes by the Exome Aggr egation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs140743001). Th is nonsense variant leads to a premature termination codon at position 12190, wh ich is predicted to lead to a truncated or absent protein. Nonsense and other tr uncating variants in TTN are strongly associated with DCM if they are located in the exons encoding for the A-band (Herman 2012, Pugh 2014) and/or are located i n an exon that is highly expressed in the heart (Roberts 2015). The p.Arg12190X variant is located in I-band in the highly expressed exon 188. In summary, alth ough additional studies are required to fully establish its clinical significanc e, the p.Arg12190X variant is likely pathogenic. - |
Cardiovascular phenotype Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The p.R5693* variant (also known as c.17077C>T), located in coding exon 66 of the TTN gene, results from a C to T substitution at nucleotide position 17077. This changes the amino acid from an arginine to a stop codon within coding exon 66. This exon is located in the I-band region of the N2-B isoform of the titin protein and is constitutively expressed in TTN transcripts (percent spliced in or PSI 100%). This variant (referred to as p.R14758X, c.44272C>T and 2:179494977G>A) has been detected in cohorts reported to have dilated cardiomyopathy (DCM) or who underwent genetic testing for DCM (Walsh R et al. Genet. Med., 2017 02;19:192-203; Vissing CR et al. J Med Genet. 2021 Dec;58(12):832-841) as well as in a 41-year-old male with atrial fibrillation and a normal echocardiogram with no evidence of cardiomyopathy (Ahlberg G et al. Nat Commun, 2018 10;9:4316). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. While truncating variants in TTN are present in 1-3% of the general population, truncating variants in the A-band are the most common cause of dilated cardiomyopathy (DCM) (Herman DS et al. N. Engl. J. Med., 2012 Feb;366:619-28; Roberts AM et al. Sci Transl Med, 2015 Jan;7:270ra6). TTN truncating variants encoded in constitutive exons (PSI >90%) have been found to be significantly associated with DCM regardless of their position in titin (Schafer S et al. Nat. Genet., 2017 01;49:46-53). As such, this alteration is classified as likely pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | May 06, 2020 | The c.36568C>T sequence change results in the creation of a premature stop codon at amino acid position 12190, p.Arg12190*. This sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated TTN protein with potentially abnormal function. This variant is present in 2 individuals in gnomAD with an overall population frequency of 0.008% (rs140743001). This variant has also been reported in an individual with dilated cardiomyopathy (PMID: 27532257). This variant is present in ClinVar and has been classified as either a variant of unknown significance or likely pathogenic by several clinical laboratories (Variation ID: 202367). The Arg12190* variant is located in one of the constitutive exons in the distal I-band region. Truncating variants in this region have been reported in individuals with autosomal recessive centronuclear myopathy (PMID: 23975875) however truncating TTN variants have been reported in approximately 3% of control alleles (PMIDs: 22335739, 26701604). Due to these contrasting evidences, the clinical significance of the p.Arg12190* change remains unknown at this time. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | May 20, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at